Company Resources
Product updates, company news, and strategic insights from Hyfe.
Product updates, company news, and strategic insights from Hyfe.

Comprehensive Chronic Cough Report reveals $15B opportunity. 100M patients, zero FDA-approved drugs, positioning digital cough monitoring as essential pharma infrastructure.

Review including Hyfe research evaluates continuous digital cough monitoring as a practical way to address limitations of patient-reported cough data

Study results demonstrate digital Behavioral Cough Suppression Therapy reduced cough frequency by over 40% in patients with refractory and unexplained chronic cough.

Strategic partnership with KYORIN Pharmaceuticals aims to improve outcomes and expand treatment access to millions impacted by chronic cough globally.



